ARROWHEAD PHARMACEUTICALS INCARROWHEAD PHARMACEUTICALS INCARROWHEAD PHARMACEUTICALS INC

ARROWHEAD PHARMACEUTICALS INC

No trades
See on Supercharts
Market capitalization
‪47.84 B‬MXN
−46.97MXN
‪−3.58 B‬MXN
‪4.20 B‬MXN
‪117.63 M‬
Beta (1Y)
1.88

About ARROWHEAD PHARMACEUTICALS INC

CEO
Christopher Richard Anzalone
Headquarters
Pasadena
Employees (FY)
525
Founded
1989
ISIN
US04280A1007
FIGI
BBG00TSG2G48
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARWR is 586.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ARROWHEAD PHARMACEUTICALS INC stocks are traded under the ticker ARWR.
ARROWHEAD PHARMACEUTICALS INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ARWR stock is 0% volatile and has beta coefficient of 1.88. Check out the list of the most volatile stocks — is ARROWHEAD PHARMACEUTICALS INC there?
One year price forecast for ARROWHEAD PHARMACEUTICALS INC has a max estimate of 1509.31 MXN and a min estimate of 469.56 MXN.
ARWR earnings for the last quarter are −17.78 MXN per share, whereas the estimation was −10.61 MXN resulting in a −67.60% surprise. The estimated earnings for the next quarter are −13.61 MXN per share. See more details about ARROWHEAD PHARMACEUTICALS INC earnings.
ARROWHEAD PHARMACEUTICALS INC revenue for the last quarter amounts to ‪280.55 M‬ MXN despite the estimated figure of ‪777.98 M‬ MXN. In the next quarter revenue is expected to reach ‪575.29 M‬ MXN.
Yes, you can track ARROWHEAD PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ARWR net income for the last quarter is ‪−2.26 B‬ MXN, while the quarter before that showed ‪−1.91 B‬ MXN of net income which accounts for −18.04% change. Track more ARROWHEAD PHARMACEUTICALS INC financial stats to get the full picture.
Today ARROWHEAD PHARMACEUTICALS INC has the market capitalization of ‪47.84 B‬, it has decreased by 4.17% over the last week.
No, ARWR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARWR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARROWHEAD PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
ARWR reached its all-time high on May 18, 2021 with the price of 1850.00 MXN, and its all-time low was 583.00 MXN and was reached on Jul 17, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 525.00 employees. See our rating of the largest employees — is ARROWHEAD PHARMACEUTICALS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARROWHEAD PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARROWHEAD PHARMACEUTICALS INC stock shows the sell signal. See more of ARROWHEAD PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ARROWHEAD PHARMACEUTICALS INC future price: according to them, ARWR price has a max estimate of 1509.31 MXN and a min estimate of 469.56 MXN. Read a more detailed ARROWHEAD PHARMACEUTICALS INC forecast: see what analysts think of ARROWHEAD PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARROWHEAD PHARMACEUTICALS INC EBITDA is ‪−4.85 B‬ MXN, and current EBITDA margin is −79.97%. See more stats in ARROWHEAD PHARMACEUTICALS INC financial statements.